Literature DB >> 27413585

Quetiapine-induced Bradycardia and Hypotension in the Elderly-A Case Report.

Masaru Nakamura1, Megumi Seki1, Yosuke Sato1, Takahiko Nagamine1.   

Abstract

Quetiapine is increasingly used for the treatment of behavioral and psychological symptoms of dementia in elderly patients. Among the many potential side effects of second-generation antipsychotics, the sudden onset of cardiac abnormality is a particularly important side effect to consider due its fatal implications. Elderly patients may be particularly vulnerable to these cardiac-related side effects due to the likelihood that they have multiple existing health conditions (e.g., heart disease, high blood pressure, diabetes) as well as age-related changes in their pharmacokinetics and pharmacodynamics and differences in their receptor binding profiles. We present a case of an elderly man with a history of heart disease who developed symptomatic bradycardia and hypotension simultaneously while taking quetiapine. After dose reduction and withdrawal of quetiapine, a time sequential improvement of bradycardia and hypotension monitored by repeated electrocardiogram and blood pressure checks suggests a relationship between the higher dosage of quetiapine and cardiac abnormalities. Other factors such as aging itself and chronic heart failure might be associated with cardiac distress. Elderly patients on quetiapine, particularly at higher dosages, should be continually and closely monitored for any symptoms of cardiac distress.

Entities:  

Keywords:  Quetiapine; bradycardia; hypotension; second generation antipsychotic

Year:  2016        PMID: 27413585      PMCID: PMC4896827     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  4 in total

1.  Antipsychotic drugs cause bradycardia in GD 13 rat embryos in vitro.

Authors:  M Gunnström; D Ababneh; W S Webster; D Oakes; H Ritchie
Journal:  Reprod Toxicol       Date:  2012-06-28       Impact factor: 3.143

Review 2.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

3.  Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions.

Authors:  E A Sotaniemi; A J Arranto; O Pelkonen; M Pasanen
Journal:  Clin Pharmacol Ther       Date:  1997-03       Impact factor: 6.875

Review 4.  Adverse effects of atypical antipsychotics in the elderly: a review.

Authors:  Pietro Gareri; Pasquale De Fazio; Salvatore De Fazio; Norma Marigliano; Guido Ferreri Ibbadu; Giovambattista De Sarro
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

  4 in total
  2 in total

Review 1.  Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Biomedicines       Date:  2021-04-26

2.  Fluphenazine decanoate-induced bradycardia: A case report.

Authors:  Mahsa Kamali; Mehran Zarghami; Marzieh Azizi; Forouzan Elyasi
Journal:  Neuropsychopharmacol Rep       Date:  2022-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.